While it is known that mutations in BRCA1 and BRCA2 markedly increase one’s risk of developing breast cancer [19, 20], a number of additional low and moderate-risk susceptibility variants have been identified, including one for caspase-8 (CASP8), an enzyme involved in apoptosis [21]. This evidence concerns the gene CASP8 and breast cancer.